Randomized comparison of G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells: effects on hematopoietic recovery after high-dose chemotherapy

Bone Marrow Transplantation
G SpitzerP Petruska

Abstract

Fifty patients with either lymphoid or selected solid tumor malignancies were apheresed an identical number of times for PBSC collection after being randomized to receive either G-CSF 10 microg/kg/day alone (arm I), or G-CSF at the same dose with GM-CSF 5 microg/kg/day (arm II). Growth factor(s) was/were given as the stem cell mobilizing agent for 5 days before the start of PBSC collection, and were continued throughout the 4 days of apheresis. Aspiration and cryopreservation of autologous bone marrow occurred on day 3 or 4 of growth factor(s). Thirty-one of 50 patients received one cycle only at time of evaluation, and 19 patients received two cycles of HDCT, each supported with PBSC with or without autologous bone marrow. No patients received growth factors post-autologous stem cell transplant, unless the absolute neutrophils count (ANC) failed to recover to > or = 100/microl by day +18 post-transplant. The median number of days to recovery of ANC to 100/microl, 500/microl and 1000/microl, and of platelet counts to 20000/microl, 50000/microl and 100000/microl after either cycle 1 or cycle 2 of HDCT and the number of febrile days and platelet and PRBC transfusion requirements was not significantly different between the two arm...Continue Reading

Citations

Jul 9, 2013·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·S TalhiM A Bekadja
Jan 14, 2009·Bone Marrow Transplantation·W BensingerJ M McCarty
Aug 30, 2011·Bone Marrow Transplantation·Ş M Bakanay, T Demirer
Oct 3, 2009·Nature Reviews. Rheumatology·Ann L CornishIan P Wicks
Mar 21, 2007·Bone Marrow Transplantation·A F CashenS M Devine
Aug 31, 2002·Journal of Hematotherapy & Stem Cell Research·Julián SevillaMiguel Angel Díaz
Jun 10, 2008·Current Opinion in Hematology·Louis M Pelus
May 23, 2012·Pathology International·Iwao Emura, Hiroyuki Usuda
Feb 7, 2007·Future Oncology·Amanda F CashenJohn DiPersio
Jul 16, 2009·Leukemia & Lymphoma·Julie M VoseJohn Dipersio
Mar 7, 2014·Expert Opinion on Biological Therapy·Massimo MartinoFrancesco Lanza
Dec 2, 2004·Expert Opinion on Biological Therapy·Rami S Komrokji, Gary H Lyman
Oct 17, 2012·Blood Reviews·Ibraheem H Motabi, John F DiPersio
Oct 4, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Panagiotis SamarasChristoph Renner
Jun 28, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Musa Karakukcu, Ekrem Unal
Jun 24, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Hakan GokerYahya Buyukasik
May 13, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Hien K DuongPaul A Carpenter
Jan 21, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Dawn SheppardJason Tay
Dec 22, 2000·Blood Reviews·S Fu, J Liesveld
Jul 28, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Immacolata AttolicoAttilio Olivieri
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven M DevineJohn F DiPersio
Dec 17, 2016·Revista da Associação Médica Brasileira·Fernando Barroso DuarteLuciano J Costa
Dec 10, 2009·The Annals of Pharmacotherapy·Lindsay L RosenbeckPatrick J Kiel
Apr 25, 2009·Circulation Research·Daniela CesselliPiero Anversa
Jul 14, 2009·Environmental Monitoring and Assessment·Faruque AhmedBarry P Roser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.